Movement Alert｜BEONE MEDICINES Intraday Rise 3.08%, JPMorgan Increases Stake to 9.05% Boosting Market Confidence

Market Focus08-18 09:36

On August 18, BEONE MEDICINES rose 3.08% in regular trading, trading at 219.4 HKD/share, with turnover of approximately 90.96 million HKD.

On the news front, JPMorgan Chase purchased 4.1197 million shares of BEONE MEDICINES on August 11 at an average price of 219.79 HKD per share, investing approximately 905 million HKD and raising its stake from 8.77% to 9.05%. The company's audit committee is scheduled to review interim results for the six months ended June 30 on August 26. The company previously disclosed H1 revenue of 22.22 billion yuan, up 26.8% year-over-year, and net profit attributable to shareholders of 3.271 billion yuan, surging 627.1% year-over-year.

Multiple institutions recently raised target prices, with CLSA upgrading to 321.7 HKD, BOCOM International to 276 HKD, and CICC maintaining 266 HKD, all assigning buy or outperform ratings. The strong institutional buying and upcoming results review have collectively bolstered market sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181981132?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 09:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181981132","market":"us","top_or_hot":-1,"title":"Movement Alert｜BEONE MEDICINES Intraday Rise 3.08%, JPMorgan Increases Stake to 9.05% Boosting Market Confidence","media":"Market Focus","content":"<p><p>On August 18, BEONE MEDICINES rose 3.08% in regular trading, trading at 219.4 HKD/share, with turnover of approximately 90.96 million HKD.</p><p>On the news front, JPMorgan Chase purchased 4.1197 million shares of BEONE MEDICINES on August 11 at an average price of 219.79 HKD per share, investing approximately 905 million HKD and raising its stake from 8.77% to 9.05%. The company's audit committee is scheduled to review interim results for the six months ended June 30 on August 26. The company previously disclosed H1 revenue of 22.22 billion yuan, up 26.8% year-over-year, and net profit attributable to shareholders of 3.271 billion yuan, surging 627.1% year-over-year.</p><p>Multiple institutions recently raised target prices, with CLSA upgrading to 321.7 HKD, BOCOM International to 276 HKD, and CICC maintaining 266 HKD, all assigning buy or outperform ratings. The strong institutional buying and upcoming results review have collectively bolstered market sentiment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜BEONE MEDICINES Intraday Rise 3.08%, JPMorgan Increases Stake to 9.05% Boosting Market Confidence</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜BEONE MEDICINES Intraday Rise 3.08%, JPMorgan Increases Stake to 9.05% Boosting Market Confidence\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-18 09:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 18, BEONE MEDICINES rose 3.08% in regular trading, trading at 219.4 HKD/share, with turnover of approximately 90.96 million HKD.</p><p>On the news front, JPMorgan Chase purchased 4.1197 million shares of BEONE MEDICINES on August 11 at an average price of 219.79 HKD per share, investing approximately 905 million HKD and raising its stake from 8.77% to 9.05%. The company's audit committee is scheduled to review interim results for the six months ended June 30 on August 26. The company previously disclosed H1 revenue of 22.22 billion yuan, up 26.8% year-over-year, and net profit attributable to shareholders of 3.271 billion yuan, surging 627.1% year-over-year.</p><p>Multiple institutions recently raised target prices, with CLSA upgrading to 321.7 HKD, BOCOM International to 276 HKD, and CICC maintaining 266 HKD, all assigning buy or outperform ratings. The strong institutional buying and upcoming results review have collectively bolstered market sentiment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1181981132","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181981132","pubTimestamp":1787016982,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 18, BEONE MEDICINES rose 3.08% in regular trading, trading at 219.4 HKD/share, with turnover of approximately 90.96 million HKD.On the news front, JPMorgan Chase purchased 4.1197 million...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"走势提醒|BEONE MEDICINES盘中上涨3.08%，摩根大通增持至9.05%，提振市场信心","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"On August 18, BEONE MEDICINES rose 3.08% in regular trading, trading at 219.4 HKD/share, with turnover of approximately 90.96 million HKD.On the news front, JPMorgan Chase purchased 4.1197 million shares of BEONE MEDICINES on August 11 at an average price of 219.79 HKD per share, investing approximately 905 million HKD and raising its stake from 8.77% to 9.05%. The company's audit committee is scheduled to review interim results for the six months ended June 30 on August 26. The company previously disclosed H1 revenue of 22.22 billion yuan, up 26.8% year-over-year, and net profit attributable to shareholders of 3.271 billion yuan, surging 627.1% year-over-year.Multiple institutions recently raised target prices, with CLSA upgrading to 321.7 HKD, BOCOM International to 276 HKD, and CICC maintaining 266 HKD, all assigning buy or outperform ratings. The strong institutional buying and upcoming results review have collectively bolstered market sentiment.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181981132","isCrawlerRequest":true}